LOCALLY ADVANCED SOLID TUMOR
Clinical trials for LOCALLY ADVANCED SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED SOLID TUMOR trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Tumor-Injected drug aims to rally immune system against cancer
Disease control TerminatedThis early-stage study tested a new drug designed to stimulate the immune system to fight cancer. The drug was injected directly into tumors, either by itself or combined with an existing immunotherapy (pembrolizumab), in people with advanced solid tumors. The main goals were to …
Matched conditions: LOCALLY ADVANCED SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Ascendis Pharma Oncology Division A/S • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Targeted drug tested for tough cancers with rare genetic flaw
Disease control TerminatedThis study tested whether the drug niraparib could help control advanced solid tumors in patients whose cancer has a specific genetic change called a PALB2 mutation. It involved 22 adults with various cancers (like breast, lung, or pancreatic) that had spread or were locally adva…
Matched conditions: LOCALLY ADVANCED SOLID TUMOR
Phase: PHASE2 • Sponsor: Tempus AI • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New cancer drug trial halted after early testing
Disease control TerminatedThis early-stage study tested a new drug called OC-001, both by itself and combined with an existing immunotherapy drug, in people with various advanced cancers that had stopped responding to standard treatments. The main goal was to check the safety of the drug and see how the b…
Matched conditions: LOCALLY ADVANCED SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Ocellaris Pharma, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC